chronic fatigue syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The inclusion criteria of subjects with CFS: 1. Consistent with the CFS diagnostic consensus (developed by the CDC in 1994): (1) persistent or recurrent fatigue lasting more than 6 months; (2) exclusion of all organic diseases causing chronic fatigue based on history, physical signs or laboratory findings. (2) and at least four of the following eight items at the same time: (1) short-term memory loss or inability to concentrate; (2) sore throat; (3) lymph node pain; (4) muscle aches and pains; (5) joint pain without redness or swelling; (6) new headache; (7) inability to recover energy after sleep; (8) discomfort for 24 consecutive hours after physical or mental work; 2. Age = 20 and = 65 years, regardless of gender; 3. Not having received any other treatment within the last 1 month 3. not received any other treatment regimen that may affect the outcome; 4. voluntarily participated in this study and signed the informed consent form. The inclusion criteria of subjects without CFS: 1. did not meet the consensus of CFS diagnosis; 2. there was no mental illness; 3. the age was = 20 years old and = 65 years old, regardless of gender; 4. those who did not accept other treatment schemes that might affect the outcome within one month; 5. those who voluntarily participated in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: Exclusion criteria for subjects with CFS: Subjects will not be enrolled if they meet any of the following criteria: 1. fatigue symptoms can be relieved with rest; 2. fatigue symptoms do not cause a substantial decrease in the ability to work, receive education, social activities, recreational activities and personal life; 3. illnesses that can clearly cause fatigue such as tumours, diabetes, rheumatic immune disease, etc.; 4. chronic illness; 5. psychiatric illness; 6. pregnant and Lactating women; 7. Those who have participated in other clinical trials within 1 month or are participating in other clinical trials; 8. Those who are not suitable for MRI, such as those with pacemakers, nerve stimulators, metallic foreign bodies (metal implants, contraceptive rings) in the body, insulin pumps, etc. Exclusion criteria for subjects without CFS: 1. Suffering from chronic diseases; 2. Pregnant and lactating women; those who have participated in other clinical trials or are participating in other clinical trials within 3.1 months; 4. Those who are not suitable for MRI examination, such as those with pacemakers, nerve stimulators, metal foreign bodies (metal implants, contraceptive rings), insulin pumps, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Child Fatigue Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Joint motion angle;Blood lactic acid;Blood oxygen concentration;Joint moment;Surface electromyography;gamma interferon;Brief profile of Mood States;Pittsburgh Sleep Quality Index;Blood immunoglobulin;transforming growth factor-ß;Quality of life scale;fMRI;Isokinetic muscle strength test;Tumor necrosis factor-a;Muscle condition rapid measurement system;Blood cortisol;Interleukin;C reactive protein; | — |
Countries
China